Inhalable Treatment Enhances Regeneration in Lung Fibrosis Model
New research suggests success of new therapeutic for idiopathic pulmonary fibrosis (IPF).
Category: Cystic fibrosis
Cystic fibrosis
Latest
Cystic fibrosis
Latest
Cystic Fibrosis Drug Kaftrio Will Become Available on NHS
The drug, Kaftrio, produced by Vertex Pharmaceuticals, will be available through the NHS to many who have cystic fibrosis.
Cystic fibrosis
Popular
Bronchiectasis Linked to Lower Risk of Lung Cancer in COPD Patients
In a recent study, researchers at the Seoul National University College of Medicine found a possible protective role for bronchiectasis against lung cancer.
Study: Tobacco Smoke and Cystic Fibrosis
New research uncovered that tobacco smoke can inhibit the therapeutic benefit of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators in children.
Read More
Classic Car Raffle to Support Cystic Fibrosis Research
On June 27 the Ohio Cobra Club will raffle a replica Shelby 427 Cobra to raise funding for research at the Cystic Fibrosis Foundation.
Read More
New York Ends Cystic Fibrosis Financial Assistance Program
New York State’s Adult Cystic Fibrosis Assistance Program (ACFAP) was defunded and will no longer be reimbursing CF patients for medical expenses.
Read MoreCF Foundation Supporting Development of Malabsorption Syndrome Therapy
The Cystic Fibrosis Foundation is supporting the development of Synspira’s SNSP003, an orally-delivered non-porcine enzyme replacement therapy (ERT) designed to treat malabsorption syndromes.
Read More
Cystic Fibrosis: Antibiotic Combo Killed M. abscessus Bacteria
A new treatment that combines three antibiotics safely eradicated Mycobacterium abscessus (M. abscessus) bacteria extracted from cystic fibrosis lungs.
Read More
Survey: Cystic Fibrosis Patients Receiving CFTR Modulators Had More Positive Health Outlooks
Cystic fibrosis patients being treated with a CFTR modulator had more positive outlooks on their futures, treatment plans, and healthcare professionals.
Read More
Three-Drug Combo Improves Lung Function in Most Common Genetic Form of Cystic Fibrosis
A phase three clinical trial that UT Southwestern participated in determined that a three-drug...
Read More
10 Tips to Reduce Unnecessary Pediatric MDI and Aerosol Treatments
Chronic lung conditions such as asthma require aerosolized pharmacological maintenance therapy, but data suggests the frequency and dosages can often be overprescribed and based on empirical assumptions rather than clinical evidence.
Read More
Trikafta Approved by FDA for Cystic Fibrosis
Trikafta is approved for patients 12 years and older with cystic fibrosis who have at least one F508del mutation in the CFTR gene, which is estimated to represent 90% of the cystic fibrosis population.
Read More
Cystic Fibrosis: Costs Forcing Parents to Argentina for Orkambi Generic
According to BBC UK, parents of children with cystic fibrosis have resorted to medical tourism to purchase a generic of the CF drug Orkambi, which is not available through the National Health Service in the UK.
Read More
Mixed Results for Orkambi in Cystic Fibrosis Patients
Orkambi appeared to improve lung function and body weight and reduce the need for intravenous antibiotic treatment in adult and pediatric cystic fibrosis patients, but 18% of patients did not tolerate the therapy.
Read More
Decrease in Cystic Fibrosis LRTIs Due to P. Aeruginosa
New research points to significant decreases in lower airway infections due to Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae among young children with cystic fibrosis.
Read More